CQC: Safer Management of Controlled Drugs Report now available
Posted by Web Team in
CQC have released their 2018 review of controlled drugs, reporting on: the increase in opioid prescribing across the UK measures ...
Read more
Posted by Web Team in
CQC have released their 2018 review of controlled drugs, reporting on: the increase in opioid prescribing across the UK measures ...
Read morePosted by Web Team in
Two further licensed melatonin products have been launched by manufacturer Colonis Pharma. Melatonin 1mg/mL oral solution (strawberry flavour) Melatonin 3mg ...
Read morePosted by Web Team in
As previously reported; the CQC analysed inspection reports, notifications of incidents and enforcement notices and then categorised the most common ...
Read morePosted by Web Team in
Slenyto prolonged-release tablets are a new licensed melatonin product. Slenyto is indicated for the treatment of insomnia in children and adolescents ...
Read morePosted by Web Team in
The MHRA Yellow Card Scheme is vital in helping the MHRA monitor the safety of all healthcare products in the ...
Read more